Companies: 10,795·Total market cap: $144.5T
Calithera Biosciences, Inc.

Calithera Biosciences, Inc.

CALAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1462
P/E Ratio
52W High$0.002
52W Low$0.0001
Overview

Calithera Biosciences, Inc. (CALA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CALA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-5.17cala eps ttm · cala earnings per shareEarnings history
PE Ratio (TTM)cala pe ratio ttm · cala price to earningsPE Ratio deep dive
Revenue (TTM)0.00cala revenue ttm · cala annual revenueFull revenue history
Dividend YieldNo Dividenddoes cala pay dividends · cala dividend yieldDividend history
Shares Outstanding5.0Mcala shares outstanding · cala floatShares outstanding history
Next EarningsAug 18, 2026Est.cala earnings date · cala next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$0.00▼ 100.00% YoY
202020212022
calithera biosciences, inc. revenue · cala revenue 2022
FY 2022Net Income-$18.9M▲ +83.61% YoY
202020212022
calithera biosciences, inc. net income · cala profit 2022
FY 2022EPS$-7.94▲ +74.52% YoY
202020212022
cala eps · calithera biosciences, inc. earnings per share 2022
TTM:Revenue: $0.00Net Income: -$20.4MEPS: $-5.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis cala a buy · cala analyst rating
Strong Buy
0
Buy
6
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$2.00Low
$0.00Current
$2.00Avg Target666566.67% upside
$2.00High
cala price target · cala 12 month forecast

Total: 10 · Buy rate: 60.0%

The CALA analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing +666566.67% upside from the current price of $0.00.

Stock Performance

Full History
1D+0.00%
1W-0.00%
1M+200.00%
3M-0.00%
YTD+200.00%
1Y-85.00%
5Y-100.00%

About Calithera Biosciences, Inc.

CEOStephanie Wong
IPO DateOct 2, 2014
Employees8
CountryUS

Calithera Biosciences, Inc. a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the…

what is calithera biosciences, inc. · cala stock overview · calithera biosciences, inc. company profile · who is calithera biosciences, inc. ceo · cala OTC · calithera biosciences, inc. headquarters · calithera biosciences, inc. business segments

About Stock Overview & Key Data

Calithera Biosciences, Inc. (CALA) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 2, 2014. As of the latest trading session, CALA stock price is $0.00, with a market capitalization of $1,462. The stock has returned -85.00% over the past 12 months and +200.00% year-to-date.

According to 10 Wall Street analysts, the consensus rating for Calithera Biosciences, Inc. stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2022, Calithera Biosciences, Inc. reported revenue of — and net income of -$18.9M. For detailed data — including Calithera Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Calithera Biosciences, Inc. (CALA) stock price is $0.00. The stock is traded on OTC under the ticker symbol CALA. The 52-week range is $0.00 – $0.00.

CALA stock priceCALA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice